loader2
Login Open ICICI 3-in-1 Account

Aarti Pharmalabs Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Aarti Pharmalabs Ltd. 12 May 2025 16:31 PM

Q4FY25 &FY25 Result Announced for Aarti Pharmalabs Ltd.

Pharmaceuticals company Aarti Pharmalabs announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Operational Revenue: Rs 5,638 million compared to Rs 5,058 million during Q4FY24, change 11.5%.
  • EBITDA: Rs 1,456 million compared to Rs 1,175 million during Q4FY24, change 23.9%.
  • EBITDA margin: 25.82% for Q4FY25.
  • PBT: Rs 1,146 million compared to Rs 957 million during Q4FY24, change 19.7%.
  • PAT: Rs 883 million compared to Rs 653 million during Q4FY24, change 35.2%.
  • PAT margin: 15.66% for Q4FY25.

FY25 Financial Highlights:

  • Operational Revenue: Rs 21,151 million compared to Rs 18,526 million during FY24, change 14.2%.
  • EBITDA: Rs 4,644 million compared to Rs 3,860 million during FY24, change 20.3%.
  • EBITDA margin: 21.96% for FY25.
  • PBT: Rs 3,607 million compared to Rs 3,005 million during FY24, change 20.0%.
  • PAT: Rs 2,724 million compared to Rs 2,169 million during FY24, change 25.6%.
  • PAT margin: 12.88% for FY25.

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app